160 related articles for article (PubMed ID: 8078510)
1. Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions.
Rupp H; Elimban V; Dhalla NS
Mol Cell Biochem; 1994 Mar; 132(1):69-80. PubMed ID: 8078510
[TBL] [Abstract][Full Text] [Related]
2. Alterations of heart function and Na+-K+-ATPase activity by etomoxir in diabetic rats.
Kato K; Chapman DC; Rupp H; Lukas A; Dhalla NS
J Appl Physiol (1985); 1999 Mar; 86(3):812-8. PubMed ID: 10066690
[TBL] [Abstract][Full Text] [Related]
3. Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir.
Rupp H; Schulze W; Vetter R
Am J Physiol; 1995 Sep; 269(3 Pt 2):R630-40. PubMed ID: 7573566
[TBL] [Abstract][Full Text] [Related]
4. CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins.
Vetter R; Rupp H
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2091-9. PubMed ID: 7810710
[TBL] [Abstract][Full Text] [Related]
5. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor.
Rupp H; Elimban V; Dhalla NS
FASEB J; 1992 Mar; 6(6):2349-53. PubMed ID: 1531968
[TBL] [Abstract][Full Text] [Related]
6. Influence of verapamil on some subcellular defects in diabetic cardiomyopathy.
Afzal N; Pierce GN; Elimban V; Beamish RE; Dhalla NS
Am J Physiol; 1989 Apr; 256(4 Pt 1):E453-8. PubMed ID: 2523196
[TBL] [Abstract][Full Text] [Related]
7. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
Schmitz FJ; Rösen P; Reinauer H
Horm Metab Res; 1995 Dec; 27(12):515-22. PubMed ID: 8750778
[TBL] [Abstract][Full Text] [Related]
8. Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure.
Rupp H; Vetter R
Br J Pharmacol; 2000 Dec; 131(8):1748-56. PubMed ID: 11139455
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-like action of intermittent fasting on sarcoplasmic reticulum Ca2+-pump ATPase and myosin isoenzymes can be prevented by sucrose.
Rupp H; Elimban V; Dhalla NS
Biochem Biophys Res Commun; 1989 Oct; 164(1):319-25. PubMed ID: 2529855
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
Zarain-Herzberg A; Rupp H
Expert Opin Investig Drugs; 2002 Mar; 11(3):345-56. PubMed ID: 11866664
[TBL] [Abstract][Full Text] [Related]
11. Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment.
Tahiliani AG; McNeill JH
Can J Physiol Pharmacol; 1985 Aug; 63(8):925-31. PubMed ID: 2934121
[TBL] [Abstract][Full Text] [Related]
12. Influence of thyroid hormone administration on myosin ATPase activity and myosin isoenzyme distribution in the heart of diabetic rats.
Dillmann WH
Metabolism; 1982 Mar; 31(3):199-204. PubMed ID: 6210824
[TBL] [Abstract][Full Text] [Related]
13. Diabetic alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase and phospholamban protein expression.
Kim HW; Ch YS; Lee HR; Park SY; Kim YH
Life Sci; 2001 Dec; 70(4):367-79. PubMed ID: 11798007
[TBL] [Abstract][Full Text] [Related]
14. Diabetes-induced abnormalities in the myocardium.
Tahiliani AG; McNeill JH
Life Sci; 1986 Mar; 38(11):959-74. PubMed ID: 2936941
[TBL] [Abstract][Full Text] [Related]
15. Myosin isoenzyme distribution and Ca+2-activated myosin ATPase activity in the rat heart is influenced by fructose feeding and triiodothyronine.
Dillmann WH
Endocrinology; 1985 Jun; 116(6):2160-6. PubMed ID: 3158509
[TBL] [Abstract][Full Text] [Related]
16. Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart.
Netticadan T; Temsah RM; Kent A; Elimban V; Dhalla NS
Diabetes; 2001 Sep; 50(9):2133-8. PubMed ID: 11522681
[TBL] [Abstract][Full Text] [Related]
17. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle.
Reinauer H; Adrian M; Rösen P; Schmitz FJ
J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671
[TBL] [Abstract][Full Text] [Related]
18. Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes.
Golfman L; Dixon IM; Takeda N; Chapman D; Dhalla NS
Mol Cell Biochem; 1999 Oct; 200(1-2):15-25. PubMed ID: 10569179
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of etomoxir treatment on cardiac Na+-K+ ATPase subunits in diabetic rats.
Kato K; Lukas A; Chapman DC; Rupp H; Dhalla NS
Mol Cell Biochem; 2002 Mar; 232(1-2):57-62. PubMed ID: 12030380
[TBL] [Abstract][Full Text] [Related]
20. Captopril treatment improves the sarcoplasmic reticular Ca(2+) transport in heart failure due to myocardial infarction.
Shao Q; Ren B; Zarain-Herzberg A; Ganguly PK; Dhalla NS
J Mol Cell Cardiol; 1999 Sep; 31(9):1663-72. PubMed ID: 10471350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
